Status:
COMPLETED
Development and Feasibility Testing of DM-BOOST Intervention.
Lead Sponsor:
Daniel Amante
Collaborating Sponsors:
Worcester Polytechnic Institute
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
DM-BOOST uses clinical informatics tools to identify types of patients with gaps in diabetes care and deploy tailored, proactive outreach methods rooted in behavioral economics to nudge them towards i...
Detailed Description
In DM-BOOST, the Principal investigator will deploy a mixed-methods, patient-centered approach to intervention development and initiate a multiphase optimization strategy (MOST) to learn how to maximi...
Eligibility Criteria
Inclusion
- Adults (age 18+)
- Cognitively able to consent (Aims 2 and 3)
- Diagnosed with type 2 diabetes (Aims 1-3)
- Receive primary care at UMMHC in past 12 months at time of initial analysis (Aims 1-3)
- English speaking (Aims 2 and 3)
- Have access to patient portal or a smart phone (Aim 3)
Exclusion
- Adults unable to consent (lacking cognitive capacity) (Aims 2 and 3)
- Individuals who are not yet adults (infants, children, teenagers) (Aims 1-3)
- Pregnant women (Aims 1-3)
- Prisoners (Aims 1-3)
- Non-English speaking (Aims 2 and 3)
Key Trial Info
Start Date :
January 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04710940
Start Date
January 13 2021
End Date
January 1 2024
Last Update
February 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Massachusetts Medical School
Worcester, Massachusetts, United States, 01655